About this event
What You’ll Learn
- Patient- and Industry-Informed Insights
- Top patient-experience pitfalls observed during ALS studies
- How operational decisions influence patient burden and engagement
What patients repeatedly highlight as barriers to participation
- Key ALS Operational Challenges and Their Solutions
- The most common operational bottlenecks seen across ALS trials
- Practical solutions developed through experience with sponsors and CROs
- How operational adjustments reduce burden and improve trial performance
Novel Approaches and Emerging Solutions
- New ways to streamline ALS trial execution
- How patient experience informs more effective trial design
- Strategies to enhance recruitment, retention, and protocol feasibility
Hosted by
-
Team member
Lieza Exalto Scientific Officer Neurology @ Julius ClinicalT
-
Guest speaker
Tommy BunteTB G
-
Team member
Julius ClinicalT
-
Guest speaker
Famke Cosijn PhD candidate at UMC Utrecht @ UMC UtrechtG
PhD candidate at the ALS Centre Netherlands, with research focused on optimising clinical trials in amyotrophic lateral sclerosis (ALS). The work aims to improve the efficiency and quality of drug development by examining key aspects of clinical trials from the perspectives of multiple stakeholders, including academia, industry, clinical trial sites, and regulators, with particular emphasis on study design and trial conduct.
-
Guest speaker
Ruben van Eijk TRICALSG
-
Guest speaker
Larah de Groot Project Director at Julius ClinicalLd G
Larah de Groot, Project Director at Julius Clinical. Larah has almost 20 years experience in the clinical research industry and has managed global phase III trials in a range of indications. She will share practical considerations on this topic, drawing from recent studies where recruitment milestones were met ahead of time.
-
Guest speaker
Rene van RijssenRv G
Julius Clinical
Global therapeutically specialized CROJulius Clinical is a global therapeutically specialized CRO that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world.
